Comparison of two commercial dentifrices in the reduction of gingivitis and plaque: A pilot study

Authors

  • Warley David Kerbauy São Paulo State University (Unesp) – Institute of Science and Technology – São José dos Campos – Department of Diagnosis and Surgery – SP – Brazil.
  • Erick Shun-Iti Maeda São Paulo State University (Unesp) – Institute of Science and Technology – São José dos Campos – Department of Diagnosis and Surgery – SP – Brazil.
  • Daniel Isaac Sendyk Department of Oral and Maxillofacial Surgery – College of Dentistry – São Paulo University – SP – Brazil.
  • Claudio Mendes Pannuti Department of Stomatology – Division of Periodontics – College of Dentistry – São Paulo University – SP – Brazil.
  • Harina Prates Vilas Boas São Paulo State University (Unesp) – Institute of Science and Technology – São José dos Campos – Department of Diagnosis and Surgery – SP – Brazil.
  • Emanuel silva Rovai Department of Stomatology – Division of Periodontics – College of Dentistry – São Paulo University – SP – Brazil.

DOI:

https://doi.org/10.14295/bds.2017.v20i4.1451

Abstract

Objectives: Chlorhexidine (CHX) and triclosan are the most used chemical agents in dentistry. However, the combination of these products has never been tested. We hypothesize that the addition of CHX to a triclosan dentifrice formulation may offer additional benefits in the reduction of plaque and gingivitis. Thus, the aim of this study was to compare a commercial dentifrice containing 0.05% chlorhexidine and 0.3% triclosan, with conventional toothpaste containing 0.3% triclosan, in the treatment of gingivitis and plaque reduction. Material and Methods: Thirty volunteers were randomly assigned to receive a dentifrice containing 0.05% CHX and 0.3% triclosan (CHX/triclosan group) or a dentifrice containing basically 0.3% triclosan (Triclosan group). Subjects received clinical evaluation such as gingival index (GI) and plaque index (PI) at baseline, 30 and 60 days. Results: After 60 days, both treatments led to a significant improvement in GI and PI. There was no significant difference between groups as regards change in GI and PI (p>0.05). Conclusion: The combination of 0.05% CHX with 0.3% triclosan did not offer further benefits to gingival inflammation and plaque control when compared with a dentifrice containing 0.3% triclosan.

Keywords

Chlorhexidine; CHX dentifrice; Triclosan; Plaque; Gingivitis.

Downloads

Download data is not yet available.

Downloads

Published

2017-12-15

How to Cite

1.
Kerbauy WD, Maeda ES-I, Sendyk DI, Pannuti CM, Boas HPV, Rovai E silva. Comparison of two commercial dentifrices in the reduction of gingivitis and plaque: A pilot study. BDS [Internet]. 2017 Dec. 15 [cited 2025 Aug. 21];20(4):71-7. Available from: https://ojs.ict.unesp.br/index.php/cob/article/view/1451

Issue

Vol. 20 No. 4 (2017): Oct. - Dec. / 2017 - Published December 2017

Section

Clinical or Laboratorial Research

License

Brazilian Dental Science uses the Creative Commons (CC-BY 4.0) license, thus preserving the integrity of articles in an open access environment. The journal allows the author to retain publishing rights without restrictions.

=================

COPYRIGHT TRANSFER AND RESPONSIBILITY STATEMENT
 (PDF)

For all articles published in the BDS journal, copyright is retained by the authors. Articles are licensed under an open-access Creative Commons CC BY 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted, provided that the original published version is cited. These conditions allow for maximum use and exposure of the work while ensuring that the authors receive proper credit. All metadata associated with published articles is released under the Creative Commons CC0 Universal Public Domain Dedication.

Before the submission, authors must obtain permission to reproduce any published material (figures, schemes, tables, or any extract of a text) that does not fall into the public domain or for which they do not hold the copyright. Permission should be requested by the authors from the copyright holder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyright holder).

The authors hereby attest that the study is original and does not present manipulated data, fraud, or plagiarism. All names listed made a significant scientific contribution to the study, are aware of the presented data, and agree with the final version of the manuscript. They assume complete responsibility for the ethical aspects of the study.

This text must be printed and signed by all authors. The scanned version should be submitted as supplemental file during the submission process.

Most read articles by the same author(s)